Alzheimer’s Drug Approval Confounds Researchers

Alzheimer’s Drug Approval Confounds Researchers
(Biogen via AP)

The US Food and Drug Administration’s (FDA) approval yesterday of the first new drug for Alzheimer’s disease in 18 years was welcomed by some patients looking for hope against an intractable condition. But for many researchers it came as a surprise — and a disappointment.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles